Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1130 | 1072 | 1251 | 1175 | 1472 | 1724 |
Fund Return | 12.97% | 7.19% | 25.11% | 5.54% | 8.04% | 5.6% |
Place in category | 384 | 351 | 278 | 160 | 272 | 167 |
% in Category | 57 | 56 | 41 | 27 | 45 | 46 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TIAA-CREF Equity Index Instl | 16.83B | 20.58 | 10.26 | 12.80 | ||
TIAA-CREF International Eq Idx Inst | 15.05B | 13.17 | 5.80 | 5.86 | ||
TIAA-CREF Large-Cap Gr Idx Instl | 13.94B | 24.48 | 11.97 | 16.46 | ||
TIAA-CREF Large-Cap Value Idx Inst | 9.35B | 16.62 | 8.99 | 9.19 | ||
TIAA-CREF S&P 500 Index Instl | 7.65B | 22.02 | 11.86 | 13.32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 214.44B | 13.49 | 3.94 | 5.36 | ||
Vanguard Total Intl Stock Index Adm | 79.67B | 13.56 | 4.01 | 5.42 | ||
Fidelity International Index Inst | 55.44B | 13.19 | 5.82 | 5.87 | ||
Fidelity Series Global ex US Index | 50.3B | 13.94 | 4.25 | 5.23 | ||
Vanguard Total Intl Stock Index I | 43.79B | 13.59 | 4.03 | 5.45 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 2.48 | 763.1 | -1.09% | |
ASML Holding | NL0010273215 | 2.00 | 621.20 | -2.02% | |
Nestle | CH0038863350 | 1.56 | 81.58 | -1.02% | |
AstraZeneca | GB0009895292 | 1.51 | 11,042.0 | -1.46% | |
Novartis | CH0012005267 | 1.32 | 93.80 | -1.63% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review